Summary & Overview
HCPCS C9482: Sotalol Hydrochloride Injection, 1 mg
HCPCS Level II code C9482 represents a parenteral administration of sotalol hydrochloride, 1 mg, used in acute management of cardiac arrhythmias and inpatient or monitored outpatient care. Nationally, this code matters for accurate capture of antiarrhythmic drug administration, billing for monitored cardiac services, and alignment of facility charges with clinical staffing and monitoring requirements.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and payer coverage considerations. The publication covers coding and billing benchmarks where available, common modifier usage, and policy or reimbursement updates that affect hospital and emergency care settings.
This summary synthesizes clinical and billing implications for hospitals, emergency departments, and outpatient facilities that administer parenteral antiarrhythmic therapy, highlighting operational and documentation points relevant to national payers and Medicare.
Billing Code Overview
HCPCS Level II code C9482 denotes an injection of sotalol hydrochloride, 1 mg. The service is an intravenous or intramuscular drug administration used to deliver the antiarrhythmic agent sotalol for acute or monitored cardiac indications. The typical site of service is hospital inpatient or outpatient settings, including observation units and emergency departments, where parenteral administration and cardiac monitoring are available.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult admitted to an inpatient cardiology unit or presenting to an emergency department with symptomatic ventricular arrhythmia or rapid atrial arrhythmia requiring acute rate or rhythm control when oral therapy is not feasible or when intravenous initiation for inpatient observation is indicated. The patient often has palpitations, syncope, presyncope, dizziness, or hemodynamic instability attributable to arrhythmia. Clinical workflow: initial evaluation by emergency medicine or cardiology includes ECG, telemetry, laboratory testing (electrolytes, renal function), and review of current medications and contraindications. After indication is confirmed and informed consent obtained, nursing prepares and verifies the sotalol hydrochloride vial and dose (billed per C9482 as 1 mg increments). A licensed clinician (cardiologist, emergency physician, or credentialed hospitalist) or advanced practice provider orders the IV administration, documents indication, informed consent, dose and route, and monitors telemetry and vitals during and after infusion. Post-administration monitoring continues for QT prolongation and arrhythmia suppression; dosing adjustments or conversion to oral sotalol are documented if appropriate. Discharge planning or inpatient follow-up includes medication reconciliation and arrhythmia clinic referral as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |